RMTI — Rockwell Medical Inc

Rockwell Medical Inc (RMTI) is a drug manufacturers - specialty & generic company listed on NASDAQ. It is led by Mark Strobeck Ph.D., based in 30142 South Wixom road, Wixom, MI, United States, 48393, with about 157 employees. Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Net income was -$1.8M. RMTI currently screens at market cap $25.7M.

Use this RMTI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RMTI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RMTI SEC filings page. Lician reads the product cache first so this HTML stays unique to Rockwell Medical Inc even when a live quote feed is slow.